Purposes
To determine the distribution and glutamate-mediated activation of NFκB members in the retina and pan-purified retinal ganglion cells (RGCs), and to characterize steps in the signal transduction events which lead to NFκB activation.
Methods
Expression patterns in the retina and RGCs were evaluated for five NFκB proteins with the aid of immunohistochemistry. Retinal explants or RGCs were treated with glutamate with or without the presence of the NDMA receptor antagonist, memantine, the calcium chelator, EGTA, or a specific inhibitor for CaMKII. Characterizations of NFκB activation were performed with the aid of electrophoretic mobility shift assays, and super shift assays.
Results
All five NFκB proteins were present in the retina and in the pan-purified RGCs. In response to a glutamate stimulus, all NFκB proteins except c-Rel were activated. P65 was unique in that it was not constitutively active but showed a glutamate-inducible activation in the retina and in the cultured RGCs. Memantine, or EGTA, or AIP inhibited NFκB activation in the retina. Furthermore, AIP significantly reduced the level of glutamate-induced degradation of IκBs.
Conclusions
These data indicate that glutamate activates distinct NFκB proteins in the retina. P65 activation may be especially important with regard to RGC responses to glutamate, given that its activity is induced by conditions which are known to lead to death of these cells. The NMDA receptor-Ca2+-CaMKII signaling pathway is involved in glutamate-induced NFκB activation. Since AIP blocks the degradation of IκB, its regulation is clearly downstream of CaMKII.